<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; BioInformatics</title>
	<atom:link href="http://www.bioscreening.net/category/news/bioinformatics/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>BioFocus to Offer IMD’s Natural Product Libraries through Drug Discovery Services</title>
		<link>http://www.bioscreening.net/2011/08/02/biofocus-to-offer-imd%e2%80%99s-natural-product-libraries-through-drug-discovery-services/</link>
		<comments>http://www.bioscreening.net/2011/08/02/biofocus-to-offer-imd%e2%80%99s-natural-product-libraries-through-drug-discovery-services/#comments</comments>
		<pubDate>Tue, 02 Aug 2011 16:44:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Diversity Libraries]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[Natural Products]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1227</guid>
		<description><![CDATA[BioFocus and InterMed Discovery (IMD) inked a marketing collaboration that will allow BioFocus to offer IMD’s natural product screening libraries through its drug discovery services. IMD will in addition provide follow-on services to BioFocus. “We have been impressed with the scale of IMD’s natural product discovery capabilities, and we believe that when InterMed’s natural product [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2011/08/02/biofocus-to-offer-imd%e2%80%99s-natural-product-libraries-through-drug-discovery-services/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Optimer Pharmaceuticals Receives Milestone Payment From Cempra for Next-Generation Macrolide Antibiotic</title>
		<link>http://www.bioscreening.net/2010/07/08/optimer-pharmaceuticals-receives-milestone-payment-from-cempra-for-next-generation-macrolide-antibiotic/</link>
		<comments>http://www.bioscreening.net/2010/07/08/optimer-pharmaceuticals-receives-milestone-payment-from-cempra-for-next-generation-macrolide-antibiotic/#comments</comments>
		<pubDate>Fri, 09 Jul 2010 03:02:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2010/07/08/optimer-pharmaceuticals-receives-milestone-payment-from-cempra-for-next-generation-macrolide-antibiotic/</guid>
		<description><![CDATA[SAN DIEGO, July 8 /PRNewswire-FirstCall/ &#8211; Optimer Pharmaceuticals, Inc. today announced it has received a $500,000 milestone payment from Cempra Pharmaceuticals, Inc. pursuant to the terms of a licensing agreement between the companies. Â The milestone payment was made as a result of Cempra&#8217;s continuing development of a next-generation macrolide (CEM-101) for the treatment of respiratory [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/07/08/optimer-pharmaceuticals-receives-milestone-payment-from-cempra-for-next-generation-macrolide-antibiotic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bioâ€™s enterprise platform wins award at Bio-IT World Expo in Boston</title>
		<link>http://www.bioscreening.net/2009/05/10/clc-bio%e2%80%99s-enterprise-platform-wins-award-at-bio-it-world-expo-in-boston/</link>
		<comments>http://www.bioscreening.net/2009/05/10/clc-bio%e2%80%99s-enterprise-platform-wins-award-at-bio-it-world-expo-in-boston/#comments</comments>
		<pubDate>Mon, 11 May 2009 00:32:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Grants and Awards]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/05/10/clc-bio%e2%80%99s-enterprise-platform-wins-award-at-bio-it-world-expo-in-boston/</guid>
		<description><![CDATA[Boston, Massachusetts, USA &#8212; April 30, 2009 &#8212; CLC bioâ€™s enterprise platform for Next Generation Sequencing data analysis, CLC Genomics Server, has just been awarded the â€œBest of Showâ€ prize at the Bio-IT World Conference &#038; Expo 2009 &#8211; an award judged by a team of Bio-IT World magazine editors and leading industry experts. Bio-IT [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/05/10/clc-bio%e2%80%99s-enterprise-platform-wins-award-at-bio-it-world-expo-in-boston/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A new approach to functional screening of siRNA knockdown</title>
		<link>http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/</link>
		<comments>http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/#comments</comments>
		<pubDate>Wed, 26 Nov 2008 17:37:56 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Cell-based Assays]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Equipment & Supplies]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[RNA Reasearch]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/</guid>
		<description><![CDATA[KINGSTON, England, Nov. 25, 2008-Guava Technologies, Inc. presented at the recent Molecular Targets &#038; Cancer Therapeutics Symposium* information on their recent advancements that describe an experimental methodology and the new GuavaÂ® Simplicity Analysis Software which exploit the advantages of plate based flow technology. These technological improvements result in an overall process that can significantly expedite [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/26/a-new-approach-to-functional-screening-of-sirna-knockdown/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Virtual Screening Gives Drug Design a Boost</title>
		<link>http://www.bioscreening.net/2008/11/19/virtual-screening-gives-drug-design-a-boost/</link>
		<comments>http://www.bioscreening.net/2008/11/19/virtual-screening-gives-drug-design-a-boost/#comments</comments>
		<pubDate>Wed, 19 Nov 2008 21:07:46 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Drug-Like Compounds]]></category>
		<category><![CDATA[HIV Research]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/19/virtual-screening-gives-drug-design-a-boost/</guid>
		<description><![CDATA[San Diego, CA (OBBeC) â€“ Researchers at the University of California, San Diego, developed a unique computational approach to identify key compounds that could lead to new drugs to combat African sleeping sickness &#8212; a disease spread by the biting tsetse fly and caused by the parasite Trypanosoma brucei. Around 150,000 people per year get [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/19/virtual-screening-gives-drug-design-a-boost/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Otava develops virtual screening system</title>
		<link>http://www.bioscreening.net/2008/11/11/otava-develops-virtual-screening-system/</link>
		<comments>http://www.bioscreening.net/2008/11/11/otava-develops-virtual-screening-system/#comments</comments>
		<pubDate>Tue, 11 Nov 2008 19:01:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/11/otava-develops-virtual-screening-system/</guid>
		<description><![CDATA[Mathematical modelling in biology is often a problem with interactions estimation between a biomolecular target and small molecule compounds. Knowledge of this interaction allows the interruption of certain processes in cells, for example it can impede diseases such as cancer. This is why so many efforts focus on designing better models and algorithms for high-throughput [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/11/otava-develops-virtual-screening-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DEFINIENS AND BIOSCAN TEAM UP FOR COOPERATIVE MARKETING EFFORTS</title>
		<link>http://www.bioscreening.net/2008/11/02/definiens-and-bioscan-team-up-for-cooperative-marketing-efforts/</link>
		<comments>http://www.bioscreening.net/2008/11/02/definiens-and-bioscan-team-up-for-cooperative-marketing-efforts/#comments</comments>
		<pubDate>Sun, 02 Nov 2008 21:52:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/02/definiens-and-bioscan-team-up-for-cooperative-marketing-efforts/</guid>
		<description><![CDATA[Morristown, New Jersey / Munich, Germany â€“ December 2, 2008 â€“ Definiens, the number one Enterprise Image Intelligenceâ„¢ company, has signed a co-marketing agreement with Bioscan, Inc., a leading developer of advanced imaging instrumentation for radiolabeled compounds.Â  Under the terms of the agreement, Bioscan and Definiens will conduct cooperative marketing activities and host joint workshops [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/02/definiens-and-bioscan-team-up-for-cooperative-marketing-efforts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tepnel Expands Genetic Services Portfolio with Addition of Illumina iScan Rapid Reader</title>
		<link>http://www.bioscreening.net/2008/10/24/tepnel-expands-genetic-services-portfolio-with-addition-of-illumina-iscan-rapid-reader/</link>
		<comments>http://www.bioscreening.net/2008/10/24/tepnel-expands-genetic-services-portfolio-with-addition-of-illumina-iscan-rapid-reader/#comments</comments>
		<pubDate>Fri, 24 Oct 2008 14:36:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[DNA Reasearch]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genetics & Pharmacogenetics]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/10/24/tepnel-expands-genetic-services-portfolio-with-addition-of-illumina-iscan-rapid-reader/</guid>
		<description><![CDATA[MANCHESTER, United Kingdom &#038; STAMFORD, Conn.&#8211;Tepnel Life Sciences PLC (AIM: TED) today announced that it has expanded its molecular genetic services offering through the addition of Illumina&#8217;s iScan System, a next-generation scanner that provides researchers conducting genetic variation studies with significantly greater throughput and application diversity. This announcement marks the first anniversary of Tepnel&#8217;s new [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/10/24/tepnel-expands-genetic-services-portfolio-with-addition-of-illumina-iscan-rapid-reader/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bio Signs Strategic Collaborative Agreement with J. Craig Venter Institute</title>
		<link>http://www.bioscreening.net/2008/10/09/clc-bio-signs-strategic-collaborative-agreement-with-j-craig-venter-institute/</link>
		<comments>http://www.bioscreening.net/2008/10/09/clc-bio-signs-strategic-collaborative-agreement-with-j-craig-venter-institute/#comments</comments>
		<pubDate>Fri, 10 Oct 2008 01:26:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/10/09/clc-bio-signs-strategic-collaborative-agreement-with-j-craig-venter-institute/</guid>
		<description><![CDATA[Cambridge, Massachusetts, USA &#8212; October 9, 2008 &#8212; CLC bio, a world leading full-service bioinformatics solution provider announced today an agreement with the J. Craig Venter Institute, a not-for profit genomic-focused research institute. The accord consists of a multi-year site license for the entire CLC bio bioinformatics suite of products. The goal is to implement [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/10/09/clc-bio-signs-strategic-collaborative-agreement-with-j-craig-venter-institute/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bio Partners with Illumina to Provide Next Generation Sequencing Analysis Technology</title>
		<link>http://www.bioscreening.net/2008/10/02/clc-bio-partners-with-illumina-to-provide-next-generation-sequencing-analysis-technology/</link>
		<comments>http://www.bioscreening.net/2008/10/02/clc-bio-partners-with-illumina-to-provide-next-generation-sequencing-analysis-technology/#comments</comments>
		<pubDate>Thu, 02 Oct 2008 22:01:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/10/02/clc-bio-partners-with-illumina-to-provide-next-generation-sequencing-analysis-technology/</guid>
		<description><![CDATA[Aarhus, Denmark &#8212; October 2, 2008 &#8212; Following an overwhelming reception of CLC Genomics Workbench 1.0, CLC bio is happy to announce the release of its next major version of their flagship product: CLC Genomics Workbench 2.0. Additionally, CLC bio has taken another important step in leading next generation sequencing data analysis byÂ  becoming an [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/10/02/clc-bio-partners-with-illumina-to-provide-next-generation-sequencing-analysis-technology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First of 100 Arab Human Genomes Sequenced by Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio</title>
		<link>http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/</link>
		<comments>http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/#comments</comments>
		<pubDate>Tue, 09 Sep 2008 19:06:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/</guid>
		<description><![CDATA[Riyadh, Kingdom of Saudi Arabia &#8212; September 9, 2008 &#8212; An international consortium consisting of Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio have in a joint effort performed an initial sequencing and analysis of the first Arab human genome, as part of a large project to sequence 100 Arab human genomes to map [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TARGET DETECTIVE CONNECTS BIOLOGICAL TARGETS TO MOLECULES</title>
		<link>http://www.bioscreening.net/2008/08/28/target-detective-connects-biological-targets-to-molecules/</link>
		<comments>http://www.bioscreening.net/2008/08/28/target-detective-connects-biological-targets-to-molecules/#comments</comments>
		<pubDate>Fri, 29 Aug 2008 00:42:05 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/08/28/target-detective-connects-biological-targets-to-molecules/</guid>
		<description><![CDATA[Tocris Bioscience (Bristol, UK) announced today the official launch of Target Detective, www.targetdetective.com, a new search facility that connects biological targets to research molecules. Target Detective represents a significant development for pre-clinical researchers working in the Life Sciences field because for the first time scientists can connect receptor, enzyme, protein and gene data to Tocris [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/08/28/target-detective-connects-biological-targets-to-molecules/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bio release white paper on the world&#8217;s fastest Next Generation Sequencing assembly algorithm</title>
		<link>http://www.bioscreening.net/2008/07/28/clc-bio-release-white-paper-on-the-worlds-fastest-next-generation-sequencing-assembly-algorithm/</link>
		<comments>http://www.bioscreening.net/2008/07/28/clc-bio-release-white-paper-on-the-worlds-fastest-next-generation-sequencing-assembly-algorithm/#comments</comments>
		<pubDate>Mon, 28 Jul 2008 23:03:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/28/clc-bio-release-white-paper-on-the-worlds-fastest-next-generation-sequencing-assembly-algorithm/</guid>
		<description><![CDATA[Aarhus Denmark &#8212; July 23, 2008 &#8212; CLC bio has just released a scientific white paper which confirms, that, in benchmarking tests, CLC bioâ€™s new algorithm for assembly of Next Generation Sequencing data is the fastest one available. Not only is CLC bioâ€™s algorithm considerably faster, but it also provides a better quality of the [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/28/clc-bio-release-white-paper-on-the-worlds-fastest-next-generation-sequencing-assembly-algorithm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC Genomics Workbench &#8211; CLC bio releases Next Generation Sequencing data analysis solution</title>
		<link>http://www.bioscreening.net/2008/07/18/clc-genomics-workbench-clc-bio-releases-next-generation-sequencing-data-analysis-solution/</link>
		<comments>http://www.bioscreening.net/2008/07/18/clc-genomics-workbench-clc-bio-releases-next-generation-sequencing-data-analysis-solution/#comments</comments>
		<pubDate>Fri, 18 Jul 2008 23:00:45 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/18/clc-genomics-workbench-clc-bio-releases-next-generation-sequencing-data-analysis-solution/</guid>
		<description><![CDATA[Aarhus, Denmark &#8212; June 12, 2008 &#8212; Today, CLC bio released their new Next Generation Sequencing (NGS) solution, CLC Genomics Workbench, which incorporates cutting-edge technology and algorithms, while also supporting and integrating with the rest of a typical NGS workflow. CLC Genomics Workbench is the first comprehensive analysis package which can analyze and visualize data [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/18/clc-genomics-workbench-clc-bio-releases-next-generation-sequencing-data-analysis-solution/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beijing Genomics Institute signs global site license with CLC bio for Next Generation Sequencing software platform</title>
		<link>http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/</link>
		<comments>http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/#comments</comments>
		<pubDate>Fri, 18 Jul 2008 21:34:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/</guid>
		<description><![CDATA[Aarhus Denmark, July 3rd, 2008 â€“ Beijing Genomics Institute (BGI) has signed a global site license agreement for CLC bio&#8217;s Next Generation Sequencing solution, CLC Genomics Workbench. The site license covers all researchers at all BGI sites, both inside and outside of China. Head of Bioinformatics Division at BGI, Ruiqiang Li states, â€œWe have chosen [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bio moves to new Headquarters in Denmark</title>
		<link>http://www.bioscreening.net/2008/07/15/clc-bio-moves-to-new-headquarters-in-denmark/</link>
		<comments>http://www.bioscreening.net/2008/07/15/clc-bio-moves-to-new-headquarters-in-denmark/#comments</comments>
		<pubDate>Tue, 15 Jul 2008 23:18:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/15/clc-bio-moves-to-new-headquarters-in-denmark/</guid>
		<description><![CDATA[Aarhus Denmark &#8212; July 10, 2008 &#8212; On July 1st, CLC bio moved their Danish headquarters to a newly built office building in the Katrinebjerg area &#8211; a fast growing Danish ICT community which also features high-tech companies Google, VMware, and B&#038;O, to name a few &#8211; as well as the University of Aarhus and [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/15/clc-bio-moves-to-new-headquarters-in-denmark/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform</title>
		<link>http://www.bioscreening.net/2008/05/07/crelux-and-proqinase-establish-joint-crystal-grade-kinase-protein-and-structures-platform/</link>
		<comments>http://www.bioscreening.net/2008/05/07/crelux-and-proqinase-establish-joint-crystal-grade-kinase-protein-and-structures-platform/#comments</comments>
		<pubDate>Wed, 07 May 2008 21:30:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/05/07/crelux-and-proqinase-establish-joint-crystal-grade-kinase-protein-and-structures-platform/</guid>
		<description><![CDATA[Munich and Freiburg, Germany, May 7, 2008 / b3c newswire / â€“ CRELUX and ProQinase announced today that they have entered into a joint agreement to supply customers with crystal-grade protein kinases and readily available kinase complex structures. Under the agreement, CRELUX and ProQinase will establish and continuously expand an off-the-shelf crystal-grade protein kinase portfolio, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/05/07/crelux-and-proqinase-establish-joint-crystal-grade-kinase-protein-and-structures-platform/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bio to collaborate with Microsoft on integrating life science technology</title>
		<link>http://www.bioscreening.net/2008/04/30/clc-bio-to-collaborate-with-microsoft-on-integrating-life-science-technology/</link>
		<comments>http://www.bioscreening.net/2008/04/30/clc-bio-to-collaborate-with-microsoft-on-integrating-life-science-technology/#comments</comments>
		<pubDate>Wed, 30 Apr 2008 21:02:04 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/04/30/clc-bio-to-collaborate-with-microsoft-on-integrating-life-science-technology/</guid>
		<description><![CDATA[Boston, USA &#8212; April 29, 2008 &#8212; Today at the Bio-IT World Conference &#038; Expo in Boston, USA, CLC bio announced collaboration with Microsoft Corp. on integrating CLC bio&#8217;s extensive bioinformatics solutions with Microsoft&#8217;s software platform, for the benefit of companies, corporations, and institutions in the biotech, pharmaceutical, and life science sectors. CLC bio has [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/04/30/clc-bio-to-collaborate-with-microsoft-on-integrating-life-science-technology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>World Premiere of Next Generation Sequencing solution from CLC bio</title>
		<link>http://www.bioscreening.net/2008/04/25/world-premiere-of-next-generation-sequencing-solution-from-clc-bio/</link>
		<comments>http://www.bioscreening.net/2008/04/25/world-premiere-of-next-generation-sequencing-solution-from-clc-bio/#comments</comments>
		<pubDate>Fri, 25 Apr 2008 21:02:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/04/25/world-premiere-of-next-generation-sequencing-solution-from-clc-bio/</guid>
		<description><![CDATA[Boston, USA &#8212; April 25, 2008 &#8212; On Monday, April 28, CLC bio will officially unveil their new Next Generation Sequencing solution, CLC Genomics Workbench, the first comprehensive analysis package which can analyze and visualize data from all the major Next Generation Sequencing (NGS) platforms, such as SOLiD from Applied Biosystems, 454 GS flx from [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/04/25/world-premiere-of-next-generation-sequencing-solution-from-clc-bio/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bio and University of Copenhagen Sign Site License Agreement</title>
		<link>http://www.bioscreening.net/2008/03/11/clc-bio-and-university-of-copenhagen-sign-site-license-agreement/</link>
		<comments>http://www.bioscreening.net/2008/03/11/clc-bio-and-university-of-copenhagen-sign-site-license-agreement/#comments</comments>
		<pubDate>Tue, 11 Mar 2008 21:05:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/03/11/clc-bio-and-university-of-copenhagen-sign-site-license-agreement/</guid>
		<description><![CDATA[Copenhagen &#038; Aarhus Denmark, March 11, 2007 &#8212; CLC bio and Department of Biology, Faculty of Science at University of Copenhagen, have signed a site license agreement for CLC bio&#8217;s premier bioinformatics software solution, CLC Combined Workbench, in combination with CLC bio&#8217;s Educational Suite. The deal runs for five years and is for several hundred [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/03/11/clc-bio-and-university-of-copenhagen-sign-site-license-agreement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

